{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:24:20Z","timestamp":1787505860486,"version":"build-2736575974"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>SMA type 1 is a severe neurodegenerative disorder that, in the absence of curative treatment, leads to death before 1 year of age without ventilatory support. Three innovative therapies are available to increase life expectancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>(i) To increase knowledge about parents' experiences with their decision to have opted for an innovative therapy; (ii) to assess the middle-term psychological consequences in the parents' lives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used an in-depth interview; a self-administrated questionnaire and self-report scales (BDI-II, STAI-Y, PSI-SF, SOC-13, PBA, DAS 16 and FICD). We compared parents hesitant before the decision to parents who were not-hesitant and the group of parents whose child was treated with gene therapy (GT) to parents whose child received another innovative therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main results<\/jats:title>\n                    <jats:p>\n                      We included\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918 parents of 13 children. Parent's mean age was 34.7 (\u00b15.2), child's average age was 44.3 months (\u00b138.0). Retrospectively, most parents felt involved by doctors in decision-making on treatment, they felt their point of view was considered and were satisfied with the effects of the treatment. The group of parents \u201cnon-hesitant\u201d was more depressed (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), more anxious (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.022) and had higher parental stress (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.026) than the group of \u201chesitant\u201d parents; the group of \u201cGT-treated\u201d parents was more depressed (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.036) than the group of parents with \u201cother therapy\u201d. Qualitative data highlights revealed: the need to save the child's life at all costs; the fear of coping with end of life and palliative care, the high value of perceived physician confidence in the treatment, the hope that the child will acquire autonomy or be cured. At the time of the decision, no parents felt they fully understood all of the issues regarding therapy and the disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hesitating before making a decision did not predispose parents to depression and anxiety. The narratives suggest that the parents faced a dilemma regarding their child's health in an urgent context. The decision was not final, and parents will continue to think about it throughout the care process.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2022.1062390","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:14:31Z","timestamp":1671596071000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Parents' dilemma: A therapeutic decision for children with spinal muscular atrophy (SMA) type 1"],"prefix":"10.3389","volume":"10","author":[{"given":"Sophie","family":"Boursange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Araneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Stalens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Desguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Barnerias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Nougues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Isapof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Quijano-Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Blu Genestine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Ouillade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maripaz","family":"Martinez Jalilie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Castiglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Boespflug-Tanguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The SMAPAR Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1172-6-71","article-title":"Spinal muscular atrophy","volume":"6","author":"D\u2019Amico","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1051\/medsci\/201834s209","article-title":"SMA in France, how many patients?","volume":"34","author":"Urtizberea","year":"2018","journal-title":"Med Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/bmjopen-2017-020907","article-title":"Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives","volume":"8","author":"Farrar","year":"2018","journal-title":"BMJ Open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fped.2020.00004","article-title":"Palliative care in SMA type 1: a prospective multicenter French study based on parents\u2019 reports","volume":"8","author":"Hully","year":"2020","journal-title":"Front Pediatr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7S9","DOI":"10.1016\/S0929-693X(20)30270-0","article-title":"Molecular diagnosis and genetic counseling for spinal muscular atrophy (SMA)","volume":"27","author":"Rouzier","year":"2020","journal-title":"Arch Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/14656566.2019.1704732","article-title":"New treatments in spinal muscular atrophy: an overview of currently available data","volume":"21","author":"Ramdas","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"B8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13023-020-01414-8","article-title":"Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study","volume":"15","author":"Audic","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JND-190424","article-title":"Advances in treatment of spinal muscular atrophy\u2014new phenotypes, new challenges, new implications for care","volume":"7","author":"Schorling","year":"2020","journal-title":"J Neuromuscul Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/jcm7090251","article-title":"New directions for SMA therapy","volume":"7","author":"Messina","year":"2018","journal-title":"J Clin Med"},{"key":"B11","first-page":"311","volume-title":"Condition de l\u2019homme moderne","author":"Arendt","year":"1961"},{"key":"B12","year":""},{"key":"B13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3917\/eres.gargi.2020.01.0157","article-title":"Nouvelles th\u00e9rapeutiques dans le champ des maladies neuromusculaires: quels enjeux?","volume-title":"Handicap et g\u00e9n\u00e9tique","author":"Bonnichon","year":"2020"},{"key":"B14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3917\/spub.121.0023","article-title":"Recherche par les m\u00e9thodes mixtes en sant\u00e9 publique: enjeux et illustration","volume":"24","author":"Gu\u00e9vel","year":"2012","journal-title":"Sant\u00e9 Publique"},{"key":"B15","volume-title":"Manual for the beck depression inventory second edition (BDI-II)","author":"Beck","year":"1996"},{"key":"B16","volume-title":"Manual for the state trait anxiety inventory","author":"Spielberger","year":"1983"},{"key":"B17","volume-title":"Manuel du STAI forme Y, adaptation fran\u00e7aise","author":"Bruchon-Scweitzer","year":"1993"},{"key":"B18","volume-title":"Parenting stress index professional manual","author":"Abidin","year":"1995"},{"key":"B19","first-page":"155","article-title":"Personality and health: testing the sense of coherence model","volume-title":"Personality and disease howard","author":"Antonovsky","year":"1990"},{"key":"B20","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fpsyg.2018.00758","article-title":"A step forward in the conceptualization and measurement of parental burnout: the parental burnout assessment (PBA)","volume":"9","author":"Roskam","year":"2018","journal-title":"Front Psychol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.encep.2006.12.005","article-title":"\u00c9chelle d\u2019ajustement dyadique: int\u00e9r\u00eats cliniques d\u2019une r\u00e9vision et validation d\u2019une version abr\u00e9g\u00e9e","volume":"34","author":"Antoine","year":"2008","journal-title":"L\u2019Enc\u00e9phale"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13668250601146753","article-title":"Parental appraisal of the family impact of childhood developmental disability: times of sadness and times of joy","volume":"32","author":"Trute","year":"2007","journal-title":"J Intellect Dev Disabil"},{"key":"B23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/13668250903496328","article-title":"Accentuate the positive to mitigate the negative: mother psychological coping resources and family adjustment in childhood disability","volume":"35","author":"Trute","year":"2010","journal-title":"J Intellect Dev Disabil"},{"key":"B24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13023-022-02407-5","article-title":"Parents as informal caregivers of children and adolescents with spinal muscular atrophy: a systematic review of quantitative and qualitative data on the psychosocial situation, caregiver burden, and family needs","volume":"17","author":"Brandt","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pedn.2018.09.007","article-title":"Identifying opportunities to provide family-centered care for families with children with type 1 spinal muscular atrophy","volume":"43","author":"Murrell","year":"2018","journal-title":"J Pediatr Nurs"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8989","DOI":"10.3390\/ijerph17238989","article-title":"The burden of spinal muscular atrophy on informal caregivers","volume":"17","author":"Aranda-Reneo","year":"2020","journal-title":"Int J Environl Res Pub Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-017-0695-0","article-title":"Social\/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain","volume":"12","author":"L\u00f3pez-Bastida","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.3390\/ijerph17165640","article-title":"The economic impact and health-related quality of life of spinal muscular atrophy. An analysis across Europe","volume":"17","author":"Pe\u00f1a-Longobardo","year":"2020","journal-title":"Int J Environ Res Pub Health"},{"key":"B29","doi-asserted-by":"publisher","first-page":"366673","DOI":"10.5152\/TurkArchPediatr.2021.20117","article-title":"The burden of primary caregivers of spinal muscular atrophy patients and their needs","volume":"56","author":"Acar","year":"2021","journal-title":"Turkish Archives of Pediatrics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"649655","DOI":"10.1093\/geront\/20.6.649","article-title":"Relatives of the impaired elderly: correlates of feelings of burden","volume":"20","author":"Zarit","year":"1980","journal-title":"Gerontologist"},{"key":"B31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/geronj\/38.3.34","article-title":"Validation of a caregiver strain index","volume":"38","author":"Robinson PhD","year":"1983","journal-title":"J Gerontol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40271-020-00415-w","article-title":"The whole game is changing and you\u2019ve got hope: Australian perspectives on treatment decision making in spinal muscular atrophy","volume":"13","author":"Farrar","year":"2020","journal-title":"Patient"},{"key":"B33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13023-020-01477-7","article-title":"Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study","volume":"15","author":"Kiefer","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.nmd.2019.02.011","article-title":"Participation and mental well-being of mothers of home-living patients with spinal muscular atrophy","volume":"29","author":"Cremers","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"B35","volume-title":"Trauma and the therapist: Counter-transfer-ence and vicarious traumatization in psychotherapy with incest survivors","author":"Pearlman","year":"1995"},{"key":"B36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.arcped.2009.02.021","article-title":"Entre agonie primitive et angoisse signal, la gen\u00e8se de l\u2019anticipation","volume":"53","author":"Missonnier","year":"2005","journal-title":"Neuropsychiatr Enf Adoles"},{"key":"B37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13023-022-02407-5","article-title":"The impact of paediatric neuromuscular disorders on parents\u2019 health-related quality of life and family functioning","volume":"26","author":"Ho","year":"2021","journal-title":"Hong Kong J Paediatr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1055\/s-0032-1304577","article-title":"Stress and coping in parents of children and adolescents with spinal muscular atrophy","volume":"224","author":"Von Gontard","year":"2012","journal-title":"Klin Padiatr"},{"key":"B39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jad.2018.08.002","article-title":"Sense of coherence, burden and mental health in caregiving: a systematic review and meta-analysis","volume":"242","author":"Del-Pino-Casado","year":"2019","journal-title":"J Affect Disord"},{"key":"B40","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1046\/j.1365-2788.2002.00414.x","article-title":"Sense of coherence in parents of children with different developmental disabilities","volume":"46","author":"Olsson","year":"2002","journal-title":"J Intellect Disabil Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/dmcn.14825","article-title":"Parents\u2019 perspectives on nusinersen treatment for children with spinal muscular atrophy","volume":"63","author":"Van Kruijsbergen","year":"2021","journal-title":"Dev Med Child Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3917\/rsi.114.0046","article-title":"Les principaux changements apport\u00e9s par la trach\u00e9otomie chez des enfants atteints de maladies neuromusculaires","volume":"114","author":"Rul","year":"2013","journal-title":"Rech Soins Infirm"},{"key":"B43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1055\/s-0042-1743439","article-title":"Parents\u2019 perspectives on diagnosis and decision-making regarding ventilator support in children with SMA type 1","volume":"53","author":"Pechmann","year":"2022","journal-title":"Neuropediatrics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/0883073818822900","article-title":"Parents\u2019 experiences of information and decision making in the care of their child with severe spinal muscular atrophy","volume":"34","author":"Beernaert","year":"2019","journal-title":"J Child Neurol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/08830738211040292","article-title":"Parent perceptions in choosing treatment for infants with spinal muscular atrophy diagnosed through newborn screening","volume":"37","author":"Deng","year":"2022","journal-title":"J Child Neurol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejpn.2020.07.001","article-title":"European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy","volume":"28","author":"Kirschner","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejpn.2020.11.003","article-title":"A decision for life\u2014treatment decisions in newly diagnosed families with spinal muscular atrophy","volume":"30","author":"Gusset","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.nmd.2020.03.00","article-title":"Randomisation versus prioritisation in a managed access programme: lessons from spinal muscular atrophy","volume":"30","author":"Servais","year":"2020","journal-title":"Neuromuscul Disord"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1062390\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:14:39Z","timestamp":1671596079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1062390\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":48,"alternative-id":["10.3389\/fped.2022.1062390"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1062390","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"article-number":"1062390"}}